This Article Full Text Full Text (PDF) All Versions of this Article: 148/9/4162    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kilic, A. Articles by Kuhn, M. Search for Related Content PubMed PubMed Citation Articles by Kilic, A. Articles by Kuhn, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH

Local Actions of Atrial Natriuretic Peptide Counteract Angiotensin II Stimulated Cardiac Remodeling

Ana Kili¹, Alexander Bubikat¹, Birgit Gaßner, Hideo A. Baba and Michaela Kuhn

Institute of Physiology (A.K., A.B., B.G., M.K.), University of Würzburg, 97070 Würzburg, Germany; and Institute of Pathology (H.A.B.), University of Duisburg-Essen, 47057 Duisburg, Germany

Address all correspondence and requests for reprints to: Michaela Kuhn, Physiologisches Institut der Universität Würzburg, Röntgenring 9, D-97070 Würzburg, Germany. E-mail: michaela.kuhn{at}mail.uni-wuerzburg.de.

The cardiac hormones atrial and brain natriuretic peptides (NPs) counteract the systemic, hypertensive, and hypervolemic actions of angiotensin II (Ang II) via their guanylyl cyclase-A (GC-A) receptor. In the present study, we took advantage of genetically modified mice with conditional, cardiomyocyte (CM)-restricted disruption of GC-A (CM GC-A knockout mice) to study whether NPs can moderate not only the endocrine but also the cardiac actions of Ang II in vivo. Fluorometric measurements of [Ca²⁺]_i transients in isolated, electrically paced adult CMs showed that atrial NP inhibits the stimulatory effects of Ang II on free cytosolic Ca²⁺ transients via GC-A. Remarkably, GC-A-deficient CMs exhibited greatly enhanced [Ca²⁺]_i responses to Ang II, which was partly related to increased activation of the Na⁺/H⁺-exchanger NHE-1. Chronic administration of Ang II to control and CM GC-A knockout mice (300 ng/kg body weight per minute via osmotic minipumps during 2 wk) provoked significant cardiac hypertrophy, which was markedly exacerbated in the later genotype. This was concomitant to increased cardiac expression of NHE-1 and enhanced activation of the Ca²⁺/calmodulin-dependent prohypertrophic signal transducers Ca²⁺/calmodulin-dependent kinase II and calcineurin. On the basis of these results, we conclude that NPs exert direct local, GC-A-mediated myocardial effects to antagonize the [Ca²⁺]_i-dependent hypertrophic growth response to Ang II.

This article has been cited by other articles:

				L. R. Forte Jr. Atriopeptins: Protection from Myocardial Hypertrophy and Heart Failure Endocrinology, September 1, 2007; 148(9): 4160 - 4161. [Full Text] [PDF]